Pinto Joshua

Pinto Joshua is listed in filings as President at Neumora Therapeutics, Inc. Common Stock. This profile follows SEC Form 4 activity through Feb 19, 2026, including sale activity. Recent filings connect the profile to Neumora Therapeutics, Inc. Common Stock (NMRA) and Metsera, Inc. (MTSR). The current snapshot covers public activity from Feb 18, 2025 to Feb 19, 2026. Reported amounts are shown as $21.1K to $645.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.